U.S. markets open in 4 hours 40 minutes
  • S&P Futures

    3,860.00
    +40.75 (+1.07%)
     
  • Dow Futures

    31,975.00
    +199.00 (+0.63%)
     
  • Nasdaq Futures

    12,555.00
    +257.75 (+2.10%)
     
  • Russell 2000 Futures

    2,233.50
    +32.70 (+1.49%)
     
  • Crude Oil

    65.41
    +0.36 (+0.55%)
     
  • Gold

    1,700.10
    +22.10 (+1.32%)
     
  • Silver

    25.78
    +0.51 (+2.02%)
     
  • EUR/USD

    1.1906
    +0.0054 (+0.45%)
     
  • 10-Yr Bond

    1.5960
    0.0000 (0.00%)
     
  • Vix

    24.72
    +0.06 (+0.24%)
     
  • GBP/USD

    1.3896
    +0.0074 (+0.53%)
     
  • USD/JPY

    108.6800
    -0.2210 (-0.20%)
     
  • BTC-USD

    54,198.46
    +4,431.55 (+8.90%)
     
  • CMC Crypto 200

    1,093.66
    +69.45 (+6.78%)
     
  • FTSE 100

    6,741.36
    +22.23 (+0.33%)
     
  • Nikkei 225

    29,027.94
    +284.69 (+0.99%)
     

Sabra Health Care REIT, Inc. to Participate in The JMP Securities Financial Services and Real Estate Conference and Berenberg US CEO Conference 2020

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chairman and Chief Executive Officer, Harold Andrews, the company’s Chief Financial Officer, Talya Nevo-Hacohen, the company’s Chief Investment Officer, and Michael Costa, the company’s Executive Vice President of Finance, will be participating in The JMP Securities Financial Services and Real Estate Conference on November 12, 2020.

Additionally, on November 13, 2020, Mr. Matros, Mr. Andrews, Ms. Nevo-Hacohen and Mr. Costa will participate in the Berenberg US CEO Conference.

About Sabra

Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201029005137/en/

Contacts

Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com